Current HIV/AIDS Reports

, Volume 12, Issue 2, pp 238–245 | Cite as

Engagement of Traditional Healers and Birth Attendants as a Controversial Proposal to Extend the HIV Health Workforce

  • Carolyn M. Audet
  • Erin Hamilton
  • Leighann Hughart
  • Jose Salato
The Global Epidemic (SH Vermund, Section Editor)
Part of the following topical collections:
  1. Topical Collection on The Global Epidemic

Abstract

“Medical pluralism” is the use of multiple health systems and is common among people living with HIV/AIDS in sub-Saharan Africa. Healers and traditional birth attendants (TBAs) often are a patient’s first and/or preferred line of treatment; this often results in delayed, interrupted, or abandoned diagnosis and therapy. Literature from the study of medical pluralism suggests that HIV care and treatment programs are infrequently and inconsistently engaging healers around the world. Mistrust and misunderstanding among patients, clinical providers, and traditional practitioners make the development of effective partnerships difficult, particularly regarding early HIV diagnosis and antiretroviral therapy. We provide recommendations for the development of successful collaboration health workforce efforts based on both published articles and case studies from our work in rural Mozambique.

Keywords

HIV/AIDS Traditional healer Traditional birth attendant Community engagement Community-clinic linkage Community health worker Testing referral Antenatal care (ANC) Elimination of mother-to-child transmission (EMTCT) Sub-Saharan Africa Mozambique 

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Moshabela M et al. Patterns and implications of medical pluralism among HIV/AIDS patients in rural South Africa. AIDS Behav. 2011;15(4):842–52.CrossRefPubMedGoogle Scholar
  2. 2.
    Okome-Nkoumou M et al. Delay between first HIV-related symptoms and diagnosis of HIV infection in patients attending the internal medicine department of the Fondation Jeanne Ebori (FJE), Libreville, Gabon. HIV Clin Trials. 2005;6(1):38–42.CrossRefPubMedGoogle Scholar
  3. 3.
    Peltzer K et al. Traditional complementary and alternative medicine and antiretroviral treatment adherence among HIV patients in Kwazulu-Natal, South Africa. Afr J Tradit Complement Altern Med. 2010;7(2):125–37.PubMedCentralGoogle Scholar
  4. 4.
    Peltzer K et al. Antiretrovirals and the use of traditional, complementary and alternative medicine by HIV patients in Kwazulu-Natal, South Africa: a longitudinal study. Afr J Tradit Complement Altern Med. 2011;8(4):337–45.PubMedCentralPubMedGoogle Scholar
  5. 5.
    Bodeker G, Willcox M. New research initiative on plant-based antimalarials. Lancet. 2000;355(9205):761.CrossRefPubMedGoogle Scholar
  6. 6.
    Homsy J et al. Traditional health practitioners are key to scaling up comprehensive care for HIV/AIDS in sub-Saharan Africa. AIDS. 2004;18(12):1723–5.CrossRefPubMedGoogle Scholar
  7. 7.
    Homsy J et al. Defining minimum standards of practice for incorporating African traditional medicine into HIV/AIDS prevention, care, and support: a regional initiative in eastern and southern Africa. J Altern Complement Med. 2004;10(5):905–10.CrossRefPubMedGoogle Scholar
  8. 8.
    Babb DA et al. Use of traditional medicine by HIV-infected individuals in South Africa in the era of antiretroviral therapy. Psychol Health Med. 2007;12(3):314–20.CrossRefPubMedGoogle Scholar
  9. 9.
    Bodeker G. Complementary medicine and evidence. Ann Acad Med Singapore. 2000;29(1):3–6.PubMedGoogle Scholar
  10. 10.
    Burford G et al. Traditional medicine and HIV/AIDS in Africa: a report from the International Conference on Medicinal Plants, Traditional Medicine and Local Communities in Africa (a parallel session to the Fifth Conference of the Parties to the Convention on Biological Diversity, Nairobi, Kenya, May 16–19, 2000). J Altern Complement Med. 2000;6(5):457–71.CrossRefPubMedGoogle Scholar
  11. 11.
    Fleming J. Mozambican healers join government in fight against AIDS. J Int Assoc Physicians AIDS Care. 1995;1(2):32.PubMedGoogle Scholar
  12. 12.
    Green EC. Traditional healers and AIDS in Uganda. J Altern Complement Med. 1999;6(1):1–2.CrossRefGoogle Scholar
  13. 13.
    Green EC. The participation of Africa Traditional Healers in AIDS/STI prevention programmes. AIDSLink. 1995;26:14–5.Google Scholar
  14. 14.
    Green EC, Zokwe B, Dupree JD. The experience of an AIDS prevention program focused on South African traditional healers. Soc Sci Med. 1995;40(4):503–15.CrossRefPubMedGoogle Scholar
  15. 15.
    Green EC. AIDS and STDs in Africa: bridging the gap between traditional healing and modern medicine. Boulder: Westview Press; 1994.Google Scholar
  16. 16.
    King R. Collaboration with traditional healers in HIV/AIDS prevention and care in sub-Saharan Africa: a literature review. UNAIDS Best Practices Collection 2000.Google Scholar
  17. 17.
    Liverpool J et al. Western medicine and traditional healers: partners in the fight against HIV/AIDS. J Natl Med Assoc. 2004;96(6):822–5.PubMedCentralPubMedGoogle Scholar
  18. 18.
    Mills E et al. The challenges of involving traditional healers in HIV/AIDS care. Int J STD AIDS. 2006;17(6):360–3.CrossRefPubMedGoogle Scholar
  19. 19.
    Morris K. South Africa tests traditional medicines. Lancet Infect Dis. 2002;2(6):319.CrossRefPubMedGoogle Scholar
  20. 20.
    Munk K. Traditional healers, traditional hospitals and HIV / AIDS: a case study in KwaZulu-Natal. AIDS Anal Afr. 1997;7(6):10–2.PubMedGoogle Scholar
  21. 21.
    Kale R. Traditional healers in South Africa: a parallel health care system. BMJ. 1995;310(6988):1182–5.CrossRefPubMedCentralPubMedGoogle Scholar
  22. 22.
    Pfeiffer J. Commodity fetichismo, the Holy Spirit, and the turn to Pentecostal and African Independent Churches in Central Mozambique. Cult Med Psychiatry. 2005;29(3):255–83.CrossRefPubMedGoogle Scholar
  23. 23.
    Audet CM et al. Sociocultural and epidemiological aspects of HIV/AIDS in Mozambique. BMC Int Health Hum Rights. 2010;10:15.CrossRefPubMedCentralPubMedGoogle Scholar
  24. 24.
    Audet CM et al. Health seeking behavior and HIV Knowledge in Zambezia Province, Mozambique. SAHARAJ. 2012;9(1):41–6.Google Scholar
  25. 25.
    Audet CM et al. HIV/AIDS-related attitudes and practices among traditional healers in Zambezia Province, Mozambique. J Altern Complement Med. 2012;18(12):1–9.Google Scholar
  26. 26.
    Audet CM et al. Poor quality health services and lack of program support leads to low uptake of HIV testing in rural Mozambique. J Afr AIDS Res. 2012;4:327–35.CrossRefGoogle Scholar
  27. 27.••
    Audet CM et al. Educational intervention increased referrals to allopathic care by traditional healers in three high HIV-prevalence rural districts in Mozambique. PLoS One. 2013;8(8):e70326. This article provides an example of implementing an educational intervention to increase healer patient referrals in rural SSA. Highlights two difficulties in the development of an effective traditional practitioner partnership, including: (1) identifying which healers to partner with; and (2) how to engage clinicians effectively.CrossRefPubMedCentralPubMedGoogle Scholar
  28. 28.••
    Audet CM, et al. Symptomatic HIV-positive persons in rural Mozambique who first consult a traditional healer have delays in HIV testing: a cross-sectional study. J Acquir Immune Defic Syndr. 2014;66(4):e80–6. This article presents the results of a cross-sectional study detailing the health seeking behavior of undiagnosed symptomatic HIV-infected patients in rural Mozambique. This study reveals that people who first visited a traditional healer had significant delays to testing . Google Scholar
  29. 29.••
    Horwitz RH, et al. No association found between traditional healer use and delayed antiretroviral initiation in rural Uganda. AIDS Behav. 2012;17(1):260–5. This article presents the results of a cross-sectional study detailing the health seeking behavior of newly diagnosed HIV-infected patients in rural Uganda. This study reveals no impact of healer use on patient outcomes.Google Scholar
  30. 30.
    Vermund SH, Allen KL, Karim QA. HIV-prevention science at a crossroads: advances in reducing sexual risk. Curr Opin HIV AIDS. 2009;4(4):266–73.CrossRefPubMedCentralPubMedGoogle Scholar
  31. 31.
    Modjarrad K, Chamot E, Vermund SH. Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression. AIDS. 2008;22(16):2179–85.CrossRefPubMedCentralPubMedGoogle Scholar
  32. 32.
    Attia S et al. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009;23(11):1397–404.CrossRefPubMedGoogle Scholar
  33. 33.
    Quinn TC et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000;342(13):921–9.CrossRefPubMedGoogle Scholar
  34. 34.
    Quinn TC. Viral load, circumcision and heterosexual transmission. Hopkins HIV Rep. 2000;12(3):1. 5, 11.PubMedGoogle Scholar
  35. 35.
    Naba MR et al. Profile of opportunistic infections in HIV-infected patients at a tertiary care center in Lebanon. J Infect Public Health. 2010;3(3):130–3.CrossRefPubMedGoogle Scholar
  36. 36.
    Thompson MA et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA. 2010;304(3):321–33.CrossRefPubMedGoogle Scholar
  37. 37.
    Fowler MG et al. Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial. J Acquir Immune Defic Syndr. 2014;65(3):366–74.CrossRefPubMedCentralPubMedGoogle Scholar
  38. 38.
    Lallemant M et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med. 2000;343(14):982–91.CrossRefPubMedGoogle Scholar
  39. 39.
    Guay LA et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354(9181):795–802.CrossRefPubMedGoogle Scholar
  40. 40.
    Kalembo FW, Zgambo M. Loss to followup: a major challenge to successful implementation of prevention of mother-to-child transmission of HIV-1 Programs in Sub-Saharan Africa. ISRN AIDS. 2012;2012:589817.CrossRefPubMedCentralPubMedGoogle Scholar
  41. 41.
    Bastard M et al. Adults receiving HIV care before the start of antiretroviral therapy in sub-Saharan Africa: patient outcomes and associated risk factors. J Acquir Immune Defic Syndr. 2013;64(5):455–63.CrossRefPubMedGoogle Scholar
  42. 42.
    Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007;4(10):e298.CrossRefPubMedCentralPubMedGoogle Scholar
  43. 43.
    World Health Organization. Retention in HIV programmes: defining the challenges and identifying solutions, H.A. Programme, Editor 2011: Geneva.Google Scholar
  44. 44.
    Cordier W, Steenkamp V. Drug interactions in African herbal remedies. Drug Metabol Drug Interact. 2011;26(2):53–63.CrossRefPubMedGoogle Scholar
  45. 45.
    Langlois-Klassen D et al. Use of traditional herbal medicine by AIDS patients in Kabarole District, western Uganda. Am J Trop Med Hyg. 2007;77(4):757–63.PubMedGoogle Scholar
  46. 46.
    Langlois-Klassen D, Kipp W, Rubaale T. Who’s talking? Communication between health providers and HIV-infected adults related to herbal medicine for AIDS treatment in western Uganda. Soc Sci Med. 2008;67(1):165–76.CrossRefPubMedGoogle Scholar
  47. 47.
    Mills E et al. African herbal medicines in the treatment of HIV: Hypoxis and Sutherlandia. An overview of evidence and pharmacology. Nutr J. 2005;4:19.CrossRefPubMedCentralPubMedGoogle Scholar
  48. 48.
    Hull MW, Wu Z, Montaner JS. Optimizing the engagement of care cascade: a critical step to maximize the impact of HIV treatment as prevention. Curr Opin HIV AIDS. 2012;7(6):579–86.CrossRefPubMedGoogle Scholar
  49. 49.
    Peltzer K, Mngqundaniso N. Patients consulting traditional health practioners in the context of HIV/AIDS in urban areas in KwaZulu-Natal, South Africa. Afr J Tradit Complement Altern Med. 2008;5(4):370–9.PubMedCentralPubMedGoogle Scholar
  50. 50.
    Peltzer K, Mngqundaniso N, Petros G. A controlled study of an HIV/AIDS/STI/TB intervention with traditional healers in KwaZulu-Natal, South Africa. AIDS Behav. 2006;10(6):683–90.CrossRefPubMedGoogle Scholar
  51. 51.
    Peltzer K, Phaswana-Mafuya N, Treger L. Use of traditional and complementary health practices in prenatal, delivery and postnatal care in the context of HIV transmission from mother to child (PMTCT) in the Eastern Cape, South Africa. Afr J Tradit Complement Altern Med. 2009;6(2):155–62.PubMedCentralPubMedGoogle Scholar
  52. 52.
    Sankar P, Jones NL. To tell or not to tell: primary care patients’ disclosure deliberations. Arch Intern Med. 2005;165(20):2378–83.CrossRefPubMedGoogle Scholar
  53. 53.
    Arkell J et al. Factors associated with anxiety in patients attending a sexually transmitted infection clinic: qualitative survey. Int J STD AIDS. 2006;17(5):299–303.CrossRefPubMedGoogle Scholar
  54. 54.
    Harper ME et al. Traditional healers participate in tuberculosis control in The Gambia. Int J Tuberc Lung Dis. 2004;8(10):1266–8.PubMedGoogle Scholar
  55. 55.
    Kayombo EJ et al. Experience of initiating collaboration of traditional healers in managing HIV and AIDS in Tanzania. J Ethnobiol Ethnomed. 2007;3(1):6.CrossRefPubMedCentralPubMedGoogle Scholar
  56. 56.
    Poudel KC et al. Retention and effectiveness of HIV/AIDS training of traditional healers in far western Nepal. Trop Med Int Health. 2005;10(7):640–6.CrossRefPubMedGoogle Scholar
  57. 57.
    Furin J. The role of traditional healers in community-based HIV care in rural Lesotho. J Community Health. 2011;36(5):849–56.CrossRefPubMedGoogle Scholar
  58. 58.
    Ministério da Saúde and Instituto Nacional de Saude. Inquérito Nacional de Prevalência, Riscos Comportamentais e Informação sobre o HIV e SIDA em Moçambique: Relatório Preliminar sobre a Prevalência da Infecção por HIV. INSIDA 2009; Available from: http://xa.yimg.com/kq/groups/15255898/801713730/name/INSIDA.
  59. 59.
    Vermund SH et al. Poor clinical outcomes for HIV infected children on antiretroviral therapy in rural Mozambique: need for program quality improvement and community engagement. PLoS One. 2014;9(10):e110116.CrossRefPubMedCentralPubMedGoogle Scholar
  60. 60.
    Blevins M, et al. Two-year death and loss to follow-up outcomes by source of referral to HIV care for HIV-infected patients initiating antiretroviral therapy in Rural Mozambique. AIDS Res Hum Retroviruses. 2015;31(2):198–207.Google Scholar
  61. 61.
    Groh K et al. Barriers to antiretroviral therapy adherence in rural Mozambique. BMC Public Health. 2011;11:650.CrossRefPubMedCentralPubMedGoogle Scholar
  62. 62.
    da Silva M, et al. Patient loss to follow-up before antiretroviral therapy initiation in Rural Mozambique. AIDS and Behavior. 2014;6:1–13.Google Scholar
  63. 63.
    Kyomuhendo GB. Low use of rural maternity services in Uganda: impact of women’s status, traditional beliefs and limited resources. Reprod Health Matters. 2003;11(21):16–26.CrossRefPubMedGoogle Scholar
  64. 64.
    Kowalewski M, Jahn A, Kimatta SS. Why do at-risk mothers fail to reach referral level? Barriers beyond distance and cost. Afr J Reprod Health. 2000;4(1):100–9.CrossRefPubMedGoogle Scholar
  65. 65.
    Bazzano AN et al. Social costs of skilled attendance at birth in rural Ghana. Int J Gynaecol Obstet. 2008;102(1):91–4.CrossRefPubMedGoogle Scholar
  66. 66.
    Jansen I. Decision making in childbirth: the influence of traditional structures in a Ghanaian village. Int Nurs Rev. 2006;53(1):41–6.CrossRefPubMedGoogle Scholar
  67. 67.
    Ogujuyigbe PA, Liasu A. Perception and health-seeking behaviour of Nigerian women about pregnancy-related risks: strategies for improvement. J Chin Clin Med. 2007;2(11):643–54.Google Scholar
  68. 68.
    Chapman RR. Endangering safe motherhood in Mozambique: prenatal care as pregnancy risk. Soc Sci Med. 2003;57(2):355–74.CrossRefPubMedGoogle Scholar
  69. 69.
    Maimbolwa MC et al. Cultural childbirth practices and beliefs in Zambia. J Adv Nurs. 2003;43(3):263–74.CrossRefPubMedGoogle Scholar
  70. 70.
    Mrisho M et al. The use of antenatal and postnatal care: perspectives and experiences of women and health care providers in rural southern Tanzania. BMC Pregnancy Childbirth. 2009;9:10.CrossRefPubMedCentralPubMedGoogle Scholar
  71. 71.
    Torpey KE et al. Adherence support workers: a way to address human resource constraints in antiretroviral treatment programs in the public health setting in Zambia. PLoS One. 2008;3(5):e2204.CrossRefPubMedCentralPubMedGoogle Scholar
  72. 72.
    Zachariah R et al. Task shifting in HIV/AIDS: opportunities, challenges and proposed actions for sub-Saharan Africa. Trans R Soc Trop Med Hyg. 2009;103(6):549–58.CrossRefPubMedGoogle Scholar
  73. 73.
    Callaghan M, Ford N, Schneider H. A systematic review of task-shifting for HIV treatment and care in Africa. Hum Resour Health. 2010;8:8.CrossRefPubMedCentralPubMedGoogle Scholar
  74. 74.
    Ministerio da Saude (MISAU), Instituto Nacional de Estatística (INE), and ICF International (ICFI), Moçambique Inquérito Demográfico e de Saúde 2011, 2013, MISAU, INE e ICFI: Calverton, Maryland, USA.Google Scholar
  75. 75.
    Audet C, et al. Promoting male involvement in antenatal care in rural north central Mozambique, in AIDS 20142014: Melbourne, Australia.Google Scholar
  76. 76.
    Ssali A et al. Traditional healers for HIV/AIDS prevention and family planning, Kiboga District, Uganda: evaluation of a program to improve practices. AIDS Behav. 2005;9(4):485–93.CrossRefPubMedGoogle Scholar
  77. 77.•
    O’Laughlin KN et al. How treatment partners help: social analysis of an African adherence support intervention. AIDS Behav. 2012;16(5):1308–15. Describes the impact of social isolation that can result from an HIV diagnosis. The authors propose the use of treatment partners to improve the physical and social well-being of people living with HIV.CrossRefPubMedCentralPubMedGoogle Scholar
  78. 78.
    Farmer P et al. Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy). Bull World Health Organ. 2001;79(12):1145–51.PubMedCentralPubMedGoogle Scholar
  79. 79.
    Rich ML et al. Excellent clinical outcomes and high retention in care among adults in a community-based HIV treatment program in rural Rwanda. J Acquir Immune Defic Syndr. 2012;59(3):e35–42.CrossRefPubMedGoogle Scholar
  80. 80.
    Koenig SP, Leandre F, Farmer PE. Scaling-up HIV treatment programmes in resource-limited settings: the rural Haiti experience. AIDS. 2004;18 Suppl 3:S21–5.CrossRefPubMedGoogle Scholar
  81. 81.
    Farmer P et al. Community-based approaches to HIV treatment in resource-poor settings. Lancet. 2001;358(9279):404–9.CrossRefPubMedGoogle Scholar
  82. 82.
    Johnson M et al. Primary relationships, HIV treatment adherence, and virologic control. AIDS Behav. 2012;16(6):1511–21.CrossRefPubMedCentralPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Carolyn M. Audet
    • 1
    • 2
  • Erin Hamilton
    • 1
  • Leighann Hughart
    • 1
  • Jose Salato
    • 3
  1. 1.Vanderbilt Institute for Global HealthVanderbilt University School of MedicineNashvilleUSA
  2. 2.Departments of Health PolicyVanderbilt University School of MedicineNashvilleUSA
  3. 3.Friends in Global HealthMaputo and QuelimaneMozambique

Personalised recommendations